Karl Haussinger
Overview
Explore the profile of Karl Haussinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moller W, Schuschnig U, Bartenstein P, Meyer G, Haussinger K, Schmid O, et al.
J Aerosol Med Pulm Drug Deliv
. 2014 Aug;
27(4):255-63.
PMID: 25084017
Chronic rhinosinusitis (CRS) is the major disorder of the upper airways, affecting about 10-15% of the total population. Topical treatment regimens show only modest efficacy, because drug delivery to the...
2.
Moller W, Schuschnig U, Celik G, Munzing W, Bartenstein P, Haussinger K, et al.
PLoS One
. 2013 Sep;
8(9):e74991.
PMID: 24040372
Objectives: Chronic rhinosinusitis (CRS) is a common chronic disease of the upper airways and has considerable impact on quality of life. Topical delivery of drugs to the paranasal sinuses is...
3.
Frankenberger M, Ekici A, Angstwurm M, Hoffmann H, Hofer T, Heimbeck I, et al.
Immunobiology
. 2012 Mar;
218(2):169-74.
PMID: 22459269
The CD16-positive monocytes have been first described in 1988 but to date no selective defect in the number of these cells in blood has been reported. We now describe a...
4.
Ziegler-Heitbrock L, Frankenberger M, Heimbeck I, Burggraf D, Wjst M, Haussinger K, et al.
Eur Respir J
. 2012 Mar;
40(4):823-9.
PMID: 22441733
The EvA study is a European Union-funded project under the Seventh Framework Programme (FP7), which aims at defining new markers for chronic obstructive pulmonary disease (COPD) and its subtypes. The...
5.
Moller W, Schuschnig U, Khadem Saba G, Meyer G, Junge-Hulsing B, Keller M, et al.
Otolaryngol Head Neck Surg
. 2010 Feb;
142(3):382-8.
PMID: 20172385
Objective: Approximately 10 to 15 percent of the European and U.S. population have chronic rhinosinusitis, but effective treatment remains a challenge. There has been limited success using topical drug delivery...
6.
Moeller W, Schuschnig U, Meyer G, Haussinger K, Keller M, Junge-Hulsing B, et al.
Rhinology
. 2009 Nov;
47(4):405-12.
PMID: 19936368
Background: Although there is a high incidence of nasal disorders including chronic sinusitis, there is limited success in the topical drug delivery to the nose and the paranasal sinuses. This...
7.
Rosenberger A, Illig T, Korb K, Klopp N, Zietemann V, Wolke G, et al.
BMC Cancer
. 2008 Feb;
8:60.
PMID: 18298806
Background: Early onset lung cancer shows some familial aggregation, pointing to a genetic predisposition. This study was set up to investigate the role of candidate genes in the susceptibility to...
8.
Moller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P, et al.
Am J Respir Crit Care Med
. 2007 Oct;
177(4):426-32.
PMID: 17932382
Rationale: Little is known about clearance of ultrafine carbon particles from the different regions of the human lung. These particles may accumulate and present a health hazard because of their...
9.
Moller W, Barth W, Kohlhaufl M, Haussinger K, Kreyling W
Biomagn Res Technol
. 2006 May;
4:4.
PMID: 16700919
Background: Magnetic microparticles being ingested by alveolar macrophages can be used as a monitor for intracellular phagosome motions and cytoskeletal mechanical properties. These studies can be performed in the human...
10.
Moller W, Haussinger K, Ziegler-Heitbrock L, Heyder J
Respir Res
. 2006 Jan;
7:10.
PMID: 16423294
Spherical monodisperse ferromagnetic iron oxide particles of 1.9 microm geometric and 4.2 microm aerodynamic diameter were inhaled by seven patients with primary ciliary dyskinesia (PCD) using the shallow bolus technique,...